TOP NEWS BioNTech/Pfizer expect new variant impact data 'within 2 weeks' Germany's BioNTech said Friday it was urgently studying how well the coronavirus vaccine it developed with Pfizer protects against the new B.1.1.529 variant detected in South Africa. AFP
COVID-19: Dec 1 deadline: Only 3% eligible Nigerians fully vaccinated Joseph Onyekwere (Deputy Editor) and Nkechi Onyedika-Ugoeze (Abuja)
Ahead G20 summit, ILO, others demand COVID-19 ‘vaccine justice’ Tope Templer Olaiya (News Editor) and Collins Olayinka (Abuja)
Kaduna joins FG, Edo, Ondo to bar unvaccinated civil servants from offices Chukwuma Muanya (Deputy Editor, Health)